ArticleBiochemical genetics2026
Sexually Dimorphic RNA Helicase DDX3Y, But Not DDX3X, Plays a Potential Tumor-Suppressive Role in Colorectal Carcinogenesis in Males.
Article in Biochemical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Beyond its role in sex determination, the Y chromosome contains genes that regulate transcription, translation, and protein stability, thereby contributing to the pathogenesis of various male-specific diseases, including cancer. Although sex significantly influences cancer incidence and outcomes, the molecular mechanisms underlying these differences remain poorly understood. These disparities are particularly evident in colorectal cancer (CRC), where men experience higher incidence, metastasis, and mortality rates. Here, we provide the first evidence that the sexually dimorphic RNA helicase DDX3Y (DEAD-box helicase 3 Y-linked), but not its X-linked homolog DDX3X, is significantly downregulated in tumor tissues from male CRC patients (n = 22). Overexpression of DDX3Y suppressed CRC cell proliferation, invasion, and colony formation while promoting apoptosis (p < 0.01). Conversely, siRNA-mediated depletion of DDX3Y, but not DDX3X, enhanced proliferation, invasion, and colony formation in normal colorectal mucosal cells (p < 0.01). Mechanistically, DDX3Y regulated the expression of key genes involved in cell growth and invasion, including KRAS, PIK3CA, PTEN, Snail, TCF7L1, and E-cadherin, whereas DDX3X had no significant effect on these targets. Collectively, these findings identify DDX3Y as a potential male-specific tumor suppressor in CRC and support further investigation of its prognostic and therapeutic potential in colorectal cancer.
Indexed as
Identifiers
42435136What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.